Denali Therapeutics Inc. (DNLI) SEC Filing 10-Q/A Quarterly report for the period ending Saturday, June 30, 2018

PDFPDF Microsoft WordWord SubscribeRSS E-mailEmail Smartphone and TabletMobile

 Please wait while we load the requested 10-Q/A Quarterly Report. If it does not load, please click the link below:

No exhibits were included with this SEC filing.

  • Form Type: Quarterly
  • Number of times amended: 0
  • Accession Number: 0001714899-18-000022
  • Submitted to the SEC: Thursday, December 6, 2018 4:33:36 PM EST
  • Accepted by the SEC: Thursday, December 6, 2018
  • Period ending: June 2018
  • Industry: Biological Products No Disgnostic Substances